Assessment of the application for renewal of authorisation of avemix® xg 10 (Endo-1,4-beta-xylanase and endo-1,3 (4)-beta-glucanase) for chickens for fattening

3Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Following a request from the European Commission, the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) was asked to deliver a scientific opinion on the assessment of the application for renewal of authorisation of AveMix® XG 10 (endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase) for chickens for fattening. The applicant has provided evidence that the additive currently in the market complies with the existing conditions of authorisation. There is no new evidence that would lead the FEEDAP Panel to reconsider its previous conclusions. Thus, the Panel concludes that the additive remains safe for the target species, consumer and the environment under the authorised conditions of use. Regarding user safety, the additive is not considered to be a dermal or eye irritant but it is a dermal and respiratory sensitiser. There is no need for assessing the efficacy of the additive in the context of the renewal of the authorisation.

Cite

CITATION STYLE

APA

Bampidis, V., Azimonti, G., Bastos, M. de L., Christensen, H., Dusemund, B., Durjava, M. K., … Mayo, B. (2020). Assessment of the application for renewal of authorisation of avemix® xg 10 (Endo-1,4-beta-xylanase and endo-1,3 (4)-beta-glucanase) for chickens for fattening. EFSA Journal, 18(4), 1–8. https://doi.org/10.2903/j.efsa.2020.6062

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free